Table of Contents
Overview
The relevance of NOTCH1 mutations in various malignancies has been well established. However, due to minimal support in the original primary data and very few mutations reported in subsequent BL studies, this gene is very unlikely to be relevant in BL.
Experimental Evidence
Driver mutations affecting this gene in DLBCL have been experimentally demonstrated to cause a gain of function (GOF).1
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
| 3 | Mutations are unlikely to be relevant to BL | |
| 1 | High-confidence DLBCL gene | |
| 1 | High-confidence MCL gene | |
| 1 | High-confidence MZL gene |
Warnings
The variants reported in this gene in BL failed QC
Mutation incidence in large patient cohorts (GAMBL reanalysis)
DLBCL
| Entity | Collection | N | mutated | Incidence | 95% CI |
|---|---|---|---|---|---|
| DLBCL | GAMBL without Reddy | 1,089 | 61 | 0.0560 | [0.0424,0.0697] |
| DLBCL | GAMBL with Reddy | 2,088 | 95 | 0.0455 | [0.0366,0.0544] |
| DLBCL | BC | 231 | 6 | 0.0260 | [0.0055,0.0465] |
| DLBCL | Dana-Farber | 303 | 12 | 0.0396 | [0.0176,0.0616] |
| DLBCL | NCI | 470 | 42 | 0.0894 | [0.0636,0.1152] |
| DLBCL | Reddy | 999 | 34 | 0.0340 | [0.0228,0.0453] |
| DLBCL | DLBCL_ICGC | 85 | 1 | 0.0118 | [0,0.0347] |
MCL
| pathology | Collection | N | mutated | Incidence | CI |
|---|---|---|---|---|---|
| MCL | GAMBL | 160 | 9 | 0.0561 | [0.0205,0.0918] |
| MCL | BC_MCL | 103 | 6 | 0.0583 | [0.013,0.1035] |
| MCL | Barcelona | 57 | 3 | 0.0526 | [0,0.1106] |
BL
| pathology | Collection | N | mutated | Incidence | CI |
|---|---|---|---|---|---|
| BL | GAMBL without Panea | 309 | 5 | 0.0154 | [0.0017,0.0292] |
| BL | GAMBL without ICGC/Zhou | 320 | 15 | 0.0196 | [0.0046,0.0346] |
| BL | GAMBL with Panea | 410 | 17 | 0.0201 | [0.0067,0.0335] |
| BL | BLGSP | 219 | 3 | 0.0137 | [0,0.0291] |
| BL | Zhou/ICGC | 90 | 2 | 0.0222 | [0,0.0527] |
| BL | Panea | 101 | 12 | 0.1188 | [0.0557,0.1819] |
Mutation pattern and selective pressure estimates
| Entity | Missense dN/dS | Nonsense dN/dS | Q value |
|---|---|---|---|
| BL | 0.9748 | 0.000 | 1.0000 |
| FL | 0.6272 | 0.000 | 1.0000 |
| DLBCL | 0.7026 | 1.642 | 0.0913 |
NOTCH1 Hotspots
| Chromosome | Coordinate (hg19) | ref>alt | HGVSp |
|---|---|---|---|
| chr9 | 139401207 | C>T | V1288I |
| chr9 | 139401199 | G>C | D1290E |
Visualizations
Protein
View coding variants in ProteinPaint hg19 or hg38
Genome
View all variants in GenomePaint hg19 or hg38
Expression
Representative Mutations
BL
Rating ★ ☆ ☆ ☆
☆
All Mutations
BL
History
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
title Publication timing
2011-07-31 : Pasqualucci : DLBCL
2012-08-27 : Rossi : MZL
2012-12-01 : Love : BL
2013-11-05 : Bea : MCL
References
1.
Ryan
RJH, Petrovic J, Rausch DM, Zhou Y, Lareau CA, Kluk MJ, Christie AL, Lee
WY, Tarjan DR, Guo B, Donohue LKH, Gillespie SM, Nardi V, Hochberg EP,
Blacklow SC, Weinstock DM, Faryabi RB, Bernstein BE, Aster JC, Pear WS.
A B Cell Regulome Links Notch to Downstream Oncogenic
Pathways in Small B Cell Lymphomas. Cell Rep. 2017
Oct 17;21(3):784–797. PMCID: PMC5687286
2.
Love
C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi
WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L,
Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader
MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A,
Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations
in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325.
PMCID: PMC3674561
3.
Rossi D, Trifonov V, Fangazio M, Bruscaggin A,
Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C,
Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A,
Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabbò F, Serra R,
Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R, Facchetti
F, Arcaini L, Inghirami G, Bertoni F, Pileri SA, Deaglio S, Foà R,
Dalla-Favera R, Pasqualucci L, Rabadan R, Gaidano G. The coding genome
of splenic marginal zone lymphoma: Activation of NOTCH2 and
other pathways regulating marginal zone development. J Exp Med. 2012 Aug
27;209(9):1537–1551. PMCID: PMC3428941


